Board Of Directors
Bruce Carbonari Chairman of the Board
Bruce is the retired Chairman and CEO of Fortune Brands, the $7 billion consumer products company. Today, he invests and sits on boards of high potential startups and mid cap private equity companies who are focused on strategic growth. Bruce is also currently the Lead Director and Chairman of the Governance and Nominating committee of RPM International, Inc. During his 20 plus years at Fortune Brands, Bruce held many leadership positions starting with being President and CEO of Moen in 1989. Under his leadership, Moen more than quadrupled it sales to over $1 billion dollars and became the number one brand in the North America and the most profitable business within Fortune Brands. By 2000, he was the President and CEO of the Fortune Brands Home and Security Business that more than doubled to over $4 billion in sales. Being promoted to President and COO of Fortune Brands in 2005, he led the 5-year transformation of the spirits business from an underperforming business unit to becoming the fastest growing spirits business in the world. And finally under his chairmanship at Fortune Brands, he lead the split up of Fortune Brands creating significant shareholder value. Prior to joining Fortune Brands, he held positions at Forstmann Little, Stanadyne and Price Waterhouse. Bruce has been honored and inducted into numerous business hall of fames and currently involved in numerous leadership position in non-profit organizations.
Wilbur H. Gantz, III Director
Wilbur is the Executive Chairman of Naurex, Inc., a biopharmaceutical company, and the President of PathoCapital LLC, a private investment firm. Mr. Gantz was formerly Chairman and Chief Executive Officer of Ovation Pharmaceuticals, Inc., a position assumed in 2002. Previously he served as Chairman and Chief Executive Officer of PathoGenesis Corporation and as President of Baxter International Inc. Mr. Gantz serves as a director of Adams Street Partners and is a trustee of the Field Museum.
David N Jonas Director
David is the Founder, President and Chief Executive Officer of JVC Investment Partners LLC, since October 2000, a firm that provides private investment and strategic support to early stage and middle market businesses in the healthcare space. Mr. Jonas founded PHC in 2003 and was its Chairman and Chief Executive Officer until January 2014 and continue to be a member of its board of directors. Prior to founding JVC Investment Partners and PharMEDium, Mr. Jonas held a number of senior management position with Baxter including the co-founder and COO/CFO of Renal Therapy Services Worldwide Inc. a subsidiary of Baxter International Inc. Mr. Jonas served on boards of various privately held companies and non-for-profit organizations including the Chicago Medical School, Gore-Bronson Bancorp, Healthcare Venture Fund, Medica Venture Fund, IBAX Healthcare Systems. Mr Jonas received BS degree in Finance and MBA from Roosevelt University. Mr. Jonas business management experience, spanning more than 35 years, includes extensive strategic and operational experience in product development, manufacturing, sales and distribution of critical healthcare products and services.
Rich Ransom President and CEO
Rich Ransom has over 10 years of experience in selling direct to consumer OTC brands. Most recently Rich was the President of ICTV Brands, Inc. and oversaw the growth of the company from $3 million to over $40 million in annual sales. During his tenure at ICTV, Rich was involved in several product acquisitions and helped to build a global marketing and distribution platform. When Rich left ICTV, the company's products were being sold through several distribution channels including direct to consumer, live television home shopping, ecommerce, and into major mass retail chains in the United States, Canada, the United Kingdom, and Hong Kong. Rich is a graduate of Penn State University’s Smeal College of Business with a Bachelor of Science degree in Accounting. Rich also earned a Master of Business Administration degree from Delaware Valley University.